Style | Citing Format |
---|---|
MLA | Sharifi MJ, et al.. "Immune-Dysregulation Harnessing in Myeloid Neoplasms." Cancer Medicine, vol. 13, no. 17, 2024, pp. -. |
APA | Sharifi MJ, Xu L, Nasiri N, Ashjaarvan M, Soleimanzadeh H, Ganjalikhanihakemi M (2024). Immune-Dysregulation Harnessing in Myeloid Neoplasms. Cancer Medicine, 13(17), -. |
Chicago | Sharifi MJ, Xu L, Nasiri N, Ashjaarvan M, Soleimanzadeh H, Ganjalikhanihakemi M. "Immune-Dysregulation Harnessing in Myeloid Neoplasms." Cancer Medicine 13, no. 17 (2024): -. |
Harvard | Sharifi MJ et al. (2024) 'Immune-Dysregulation Harnessing in Myeloid Neoplasms', Cancer Medicine, 13(17), pp. -. |
Vancouver | Sharifi MJ, Xu L, Nasiri N, Ashjaarvan M, Soleimanzadeh H, Ganjalikhanihakemi M. Immune-Dysregulation Harnessing in Myeloid Neoplasms. Cancer Medicine. 2024;13(17):-. |
BibTex | @article{ author = {Sharifi MJ and Xu L and Nasiri N and Ashjaarvan M and Soleimanzadeh H and Ganjalikhanihakemi M}, title = {Immune-Dysregulation Harnessing in Myeloid Neoplasms}, journal = {Cancer Medicine}, volume = {13}, number = {17}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Sharifi MJ AU - Xu L AU - Nasiri N AU - Ashjaarvan M AU - Soleimanzadeh H AU - Ganjalikhanihakemi M TI - Immune-Dysregulation Harnessing in Myeloid Neoplasms JO - Cancer Medicine VL - 13 IS - 17 SP - EP - PY - 2024 ER - |